Clinical Trial Update: A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-masked study evaluating the safety and efficacy of reproxalap ophthalmic solution in adults with dry eye disease completed and post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Reproxalap ophthalmic solution (reproxalap)

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Dry Eye Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2025-02-06